Add BrightSurf on Google Email

Science News Archive March 2019 - Page 6


Page 6 of 43

Biophysicists use machine learning to understand, predict dynamics of worm behavior

Researchers used an algorithm to model the decision-making of C. elegans in response to a sensory stimulus, achieving predictions that matched experimental results. The Sir Isaac platform demonstrated improved accuracy compared to prior models, offering insights into the potential of artificial intelligence in scientific discovery.

SourceEmory Health Sciences·JournalProceedings of the National Academy of Sciences·DateMar 27, 2019

Drexel study: Smartphone app detects diet cheat

A new smartphone app called OnTrack can predict when users are likely to lapse in their weight loss plan and send personalized coaching messages to help them stay on track. The study found that participants who used the app reported high levels of satisfaction and experienced a significant reduction in unplanned lapses.

Many NHS partnerships with drug companies are out of public sight

An investigation by The BMJ found that many NHS trusts are keeping secret details of their partnerships with drug companies, despite official guidance for transparency. Joint working arrangements between the NHS and industry have spent over £7.5m on projects such as ADHD medication reviews and age-related macular degeneration treatments.

SourceBMJ Group·JournalThe BMJ·DateMar 27, 2019

Fullerenes bridge conductive gap in organic photovoltaics

Scientists create novel polymeric material with fullerenes, boosting power conversion efficiency of organic solar cells by three-fold. The new interlayer material improves device stability and electrode performance, overcoming intrinsic problems related to combining hard and soft materials.

SourceWiley·JournalAngewandte Chemie International Edition·DateMar 27, 2019

Putting the science in science communication

Nadkarni's Ambassador Model training program empowers scientists to engage the public through meaningful connections, promoting shared values and community involvement. The program's effectiveness is demonstrated through high ambassador participation rates and increased interest in science among participants.

SourceUniversity of Utah·JournalBioScience·DateMar 27, 2019

Dissolving the gordian knot

A team of researchers has identified a 'druggable' mechanism for pathological tau protein aggregation, which could lead to new treatment options for devastating neurodegenerative diseases. The discovery focuses on the RASD2 gene and its potential as a target for farnesyl transferase inhibitors.

SourceUniversity of California - Santa Barbara·JournalScience Translational Medicine·DateMar 27, 2019

Let's not make big waves

A team of researchers has successfully generated ultra-short spin waves in an astoundingly simple material, opening up new possibilities for the development of spintronics. The achievement uses a magnetic material shaped into circular disks to create spin waves with wavelengths as short as 80 nanometers.

SourceHelmholtz-Zentrum Dresden-Rossendorf·JournalPhysical Review Letters·DateMar 27, 2019

Simplified synthesis

A novel iron catalyst has been discovered to simplify and streamline organic chemical synthesis, reducing costs and waste. This breakthrough could have huge implications for industries such as pharmaceuticals and petrochemicals.

SourceUniversity of Tokyo·JournalNature Catalysis·DateMar 27, 2019

How nerve cells control misfolded proteins

A team of researchers has identified a protein complex called Lubac that marks misfolded proteins, stopping them from interacting with other proteins and directing them towards disposal. This discovery holds promise for the development of new therapeutic approaches to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.

SourceRuhr-University Bochum·JournalThe EMBO Journal·DateMar 27, 2019

Self-sustaining, bioengineered blood vessels could replace damaged vessels in patients

A team of researchers has developed self-sustaining, bioengineered blood vessels that can safely integrate into the native circulatory systems of patients. The vessels, currently being tested in phase 3 clinical trials, offer a promising alternative to replacing damaged vessels with those from human donors or animals.

SourceAmerican Association for the Advancement of Science (AAAS)·JournalScience Translational Medicine·DateMar 27, 2019